# Effect of Melatonin Administration on Systemic Lupus Erythematosus Patients

> **NCT07721324** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Ain Shams University** · enrollment: 64 (estimated)

## Conditions studied

- Therapy
- Treatment

## Interventions

- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT07721324
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-21
- **Primary completion:** 2026-10-21
- **Final completion:** 2026-11-21
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07721324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07721324, "Effect of Melatonin Administration on Systemic Lupus Erythematosus Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07721324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*